Last reviewed · How we verify
idanpramine
idanpramine is a idanpramine drug. It is currently in unknown development.
Idanpramine is thought to work by interacting with a specific target in the body, although the exact nature of this interaction is not well understood.
Idanpramine is a small molecule drug used for functional gastrointestinal disorders. It acts as an antimuscarinic agent.
At a glance
| Generic name | idanpramine |
|---|---|
| Drug class | idanpramine |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is a complex computer, and idanpramine is a software update that helps fix problems with how the computer processes information. By interacting with a specific part of the brain, idanpramine may help improve mood or other symptoms, but more research is needed to confirm this theory.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- idanpramine CI brief — competitive landscape report
- idanpramine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about idanpramine
What is idanpramine?
How does idanpramine work?
What drug class is idanpramine in?
What development phase is idanpramine in?
Related
- Drug class: All idanpramine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing